Coreline Soft, Co., Ltd.

KQ:384470 Korea Diagnostics & Research
Market Cap
$41.67 Million
₩61.02 Billion KRW
Market Cap Rank
#23126 Global
#1226 in Korea
Share Price
₩3400.00
Change (1 day)
+0.59%
52-Week Range
₩2910.00 - ₩9350.00
All Time High
₩39400.00
About

Coreline Soft Co., Ltd. develops medical software to provide diagnosis and image solution for lung diseases. It offers AVIEW Metric-Lung, a quantitative image biomarker software of COPD using chest CT images; AVIEW Modeler, a three-dimensional (3D) modeling software for 3D printing; and AVIEW Research, a software for medical research data management. The company was founded in 2012 and is based i… Read more

Coreline Soft, Co., Ltd. - Asset Resilience Ratio

Latest as of March 2025: 49.83%

Coreline Soft, Co., Ltd. (384470) has an Asset Resilience Ratio of 49.83% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₩12.39 Billion
Cash + Short-term Investments
Total Assets
₩24.86 Billion
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how Coreline Soft, Co., Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Coreline Soft, Co., Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩12.39 Billion 49.83%
Total Liquid Assets ₩12.39 Billion 49.83%

Asset Resilience Insights

  • Very High Liquidity: Coreline Soft, Co., Ltd. maintains exceptional liquid asset reserves at 49.83% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Coreline Soft, Co., Ltd. Industry Peers by Asset Resilience Ratio

Compare Coreline Soft, Co., Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF
Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860
Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for Coreline Soft, Co., Ltd. (2022–2024)

The table below shows the annual Asset Resilience Ratio data for Coreline Soft, Co., Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 47.17% ₩11.63 Billion ₩24.66 Billion -26.98pp
2023-12-31 74.14% ₩11.76 Billion ₩15.86 Billion +29.99pp
2022-12-31 44.16% ₩2.47 Billion ₩5.60 Billion --
pp = percentage points